TickerFacts.

Inmune Bio, Inc. (INMB): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

24.76M
Year ended 2025-12-31
+11.4%
3-year compound annual growth
2021-12-31: 16.13M2022-12-31: 17.93M2023-12-31: 17.98M2024-12-31: 19.94M2025-12-31: 24.76M24.76M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3124.76M+24.1%2026-03-30, From 2025-01-01
2024-12-3119.94M+10.9%2026-03-30, From 2024-01-01
2023-12-3117.98M+0.3%2025-03-27, From 2023-01-01
2022-12-3117.93M+11.1%2024-03-28, From 2022-01-01
2021-12-3116.13Mn/a2023-03-02, From 2021-01-01